Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
1992-8-31
|
pubmed:commentsCorrections | |
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0755-4982
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
952-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1386450-Aged,
pubmed-meshheading:1386450-Dose-Response Relationship, Drug,
pubmed-meshheading:1386450-Female,
pubmed-meshheading:1386450-Humans,
pubmed-meshheading:1386450-Methylprednisolone,
pubmed-meshheading:1386450-Middle Aged,
pubmed-meshheading:1386450-Purpura, Thrombocytopenic, Idiopathic
|
pubmed:year |
1992
|
pubmed:articleTitle |
[Treatment of severe idiopathic thrombocytopenic purpura with high dose of methylprednisolone].
|
pubmed:publicationType |
Letter,
Case Reports
|